Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

New molecules can prevent cell death in hair follicles.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Lower SMAD2/3 activation predicts more severe skin cancer.

Modifying steroidal inhibitors shows promise for developing new cancer treatments.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Potassium channel activators like nicotinamide and minoxidil might help treat solid tumors.

SM04554 may increase hair growth as a topical treatment for androgenetic alopecia.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

BMS-470539 reduces skin fibrosis and inflammation.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Selective androgen receptor modulators (SARMs) are a promising type of drug for various health conditions due to their targeted actions.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

DFMO may help control hair growth and treat cancer.